NIMH Pledges $2M to Study Depression Pharmacogenomics | GenomeWeb
NEW YORK (GenomeWeb News) — The National Institute of Mental Health plans to grant around $2 million to investigators who are studying ways to apply pharmacogenomics and personalized medicine technologies and techniques to the treatment of depression, the National Institutes of Health announced last week.
 
The goal of the project, which will support around seven researchers for up to three years, is to test new approaches and to develop models that will integrate specific patient characteristics into the treatment of depression.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.